Literature DB >> 9887359

Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells.

Y Nishimura1, M Sameni, B F Sloane.   

Abstract

Increased expression and alteration of intracellular trafficking of lysosomal cathepsins have been reported in malignant tumors, or in cells transformed by the transfection with the ras oncogene. In the present study, immortal MCF-10A human breast epithelial cells were transformed with the mutated ras oncogene. Both cell lines were investigated for changes in the intracellular localization of lysosomal cathepsin D and lamp-1 (lysosome-associated membrane protein) employing specific antibodies and confocal immunofluorescence microscopy. The results revealed that staining for cathepsin D along with for lamp-1 was mostly localized in the perinuclear region of MCF-10A cells. In contrast, the staining for these proteins was found to be widely distributed throughout the cytoplasm and at the cell periphery in MCF-10AneoT cells. The organization of microtubules, but not actin, appeared to differ between MCF-10A cells and their oncogenic ras transfectants. When the microtubules were depolymerized by treatment of MCF-10A cells with nocodazole, vesicles containing the lysosomal cathepsin D were dispersed in the cytoplasm and translocation of these vesicles to the cell periphery was observed. The intracellular localization of cathepsin D in the nocodazole-treated MCF-10A cells seemed to be similar to that observed in the oncogenic ras transfectants of these cells. When taxol, which inhibits microtubule depolymerization, was added to the culture medium of neoT cells, a polymerized microtubule network was observed, and the reclustering of cathepsin D and lamp-1 occurred in an unidirectional manner towards the perinuclear region. These findings support a model in which cytoskeletal microtubule organization is closely related to the trafficking of lysosomes/endosomes, and in which oncogenic ras interferes with such organization in human breast epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9887359     DOI: 10.1007/bf02905219

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  45 in total

1.  Cathepsin D in breast cancer: a tissue marker associated with metastasis.

Authors:  H Rochefort
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  Transformation of human breast epithelial cells by c-Ha-ras oncogene.

Authors:  F Basolo; J Elliott; L Tait; X Q Chen; T Maloney; I H Russo; R Pauley; S Momiki; J Caamano; A J Klein-Szanto
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

3.  Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells.

Authors:  J Ochieng; F Basolo; A Albini; A Melchiori; H Watanabe; J Elliott; A Raz; S Parodi; J Russo
Journal:  Invasion Metastasis       Date:  1991

4.  Radial extension of macrophage tubular lysosomes supported by kinesin.

Authors:  P J Hollenbeck; J A Swanson
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

5.  Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

Authors:  H D Soule; T M Maloney; S R Wolman; W D Peterson; R Brenz; C M McGrath; J Russo; R J Pauley; R F Jones; S C Brooks
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

Review 6.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.

Authors:  B F Sloane; K Moin; E Krepela; J Rozhin
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

7.  Cathepsin B and D are Localized at the Surface of Human Breast Cancer Cells.

Authors:  Mansoureh Sameni; Edith Elliott; Grace Ziegler; Philip H Fortgens; Clive Dennison; Bonnie F Sloane
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

Review 8.  Taxol: a novel investigational antimicrotubule agent.

Authors:  E K Rowinsky; L A Cazenave; R C Donehower
Journal:  J Natl Cancer Inst       Date:  1990-08-01       Impact factor: 13.506

Review 9.  Cathepsin D: a protease involved in breast cancer metastasis.

Authors:  H Rochefort; F Capony; M Garcia
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

10.  Immunolocalization of cytoplasmic dynein to lysosomes in cultured cells.

Authors:  S X Lin; C A Collins
Journal:  J Cell Sci       Date:  1992-01       Impact factor: 5.285

View more
  14 in total

1.  A role for small GTPase RhoA in regulating intracellular membrane traffic of lysosomes in invasive rat hepatoma cells.

Authors:  Yukio Nishimura; Kazuyuki Itoh; Kiyoko Yoshioka; Kazuhiko Ikeda; Masaru Himeno
Journal:  Histochem J       Date:  2002-05

2.  Targeting lysosome function causes selective cytotoxicity in VHL-inactivated renal cell carcinomas.

Authors:  Nadia Bouhamdani; Dominique Comeau; Alexandre Coholan; Kevin Cormier; Sandra Turcotte
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

3.  A role of LIM kinase 1/cofilin pathway in regulating endocytic trafficking of EGF receptor in human breast cancer cells.

Authors:  Yukio Nishimura; Kiyoko Yoshioka; Ora Bernard; Biborka Bereczky; Kazuyuki Itoh
Journal:  Histochem Cell Biol       Date:  2006-06-09       Impact factor: 4.304

4.  A novel role of Rho-kinase in the regulation of ligand-induced phosphorylated EGFR endocytosis via the early/late endocytic pathway in human fibrosarcoma cells.

Authors:  Yukio Nishimura; Biborka Bereczky; Kiyoko Yoshioka; Shun'ichiro Taniguchi; Kazuyuki Itoh
Journal:  J Mol Histol       Date:  2011-08-17       Impact factor: 2.611

Review 5.  The Achilles' heel of cancer: targeting tumors via lysosome-induced immunogenic cell death.

Authors:  Taritsa Iulianna; Neote Kuldeep; Fossel Eric
Journal:  Cell Death Dis       Date:  2022-05-30       Impact factor: 9.685

6.  Overexpression of ROCK in human breast cancer cells: evidence that ROCK activity mediates intracellular membrane traffic of lysosomes.

Authors:  Yukio Nishimura; Kazuyuki Itoh; Kiyoko Yoshioka; Kazuo Tokuda; Masaru Himeno
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

Review 7.  Targeting the lysosome in cancer.

Authors:  Shengfu Piao; Ravi K Amaravadi
Journal:  Ann N Y Acad Sci       Date:  2015-11-24       Impact factor: 5.691

Review 8.  Autophagy and organelle homeostasis in cancer.

Authors:  Dannah R Miller; Andrew Thorburn
Journal:  Dev Cell       Date:  2021-03-08       Impact factor: 12.270

9.  Supporting a role for the GTPase Rab7 in prostate cancer progression.

Authors:  Joshua J Steffan; Samantha S Dykes; David T Coleman; Lisa K Adams; Donna Rogers; Jennifer L Carroll; B Jill Williams; James A Cardelli
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

10.  The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines.

Authors:  Yukio Nishimura; Biborka Bereczky; Mayumi Ono
Journal:  Histochem Cell Biol       Date:  2007-03-15       Impact factor: 2.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.